Correspondence avaquero@idibell.cat In Brief
Bosch-Presegué et al. find that HP1a interacts with CTCF in pericentric heterochromatin (PCH) and restricts H4K20me3 and H3K27me3 distribution. Loss of HP1a results in PCH hypercompaction and a distinctive pattern of mitotic defects. HP1b is functionally related to H4K20me3 deposition and inhibits CTCF distribution, and its deficiency produces decompaction of PCH.
INTRODUCTION
The alteration of pericentric heterochromatin (PCH) organization and structure have been linked to cell-cycle-progression defects, DNA damage, chromosomal aberrations, apoptosis, cancer, and aging (Benayoun et al., 2015; Carone and Lawrence, 2013) . PCH is defined by several features including specific histone modifications, structural proteins, histone variants, DNA hypermethylation, and an undefined RNA component (Saksouk et al., 2015) . Two histone marks, H3K9me3 and H4K20me3, have been proposed as being hallmarks of PCH structure (Rea et al., 2000; Schotta et al., 2004) .
H3K9me3 is mainly catalyzed by the histone methyltransferase Suv39h1 and its close relative Suv39h2 and functions as a docking site for specific factors (Bannister et al., 2001; Lachner et al., 2001) , whereas H4K20me3 is catalyzed by Su(var)4-20h2 and is directly involved in chromatin compaction and cohesin recruitment (Hahn et al., 2013) . How these marks are distributed throughout heterochromatin and whether they co-localize in the same regions within heterochromatic regions are currently unknown. A key factor in heterochromatin structure is heterochromatin protein 1 (HP1), which was originally described in Drosophila as a suppressor of position-effect variegation (Eissenberg et al., 1990) . Mammals harbor three HP1 isotypes termed HP1a, HP1b, and HP1g (Jones et al., 2000) . A growing body of evidence suggests that the role of HP1 proteins in genome stability goes beyond heterochromatin structure as they play a role in gene expression, DNA replication, DNA repair, cell cycle, cell differentiation, and development (Maison and Almouzni, 2004) . All three isoforms localize to PCH although HP1b and HP1g are also found in euchromatic regions (Maison and Almouzni, 2004) . HP1 proteins participate in the establishment and propagation of the heterochromatin structure through their specific binding both to H3K9me3 and Suv39h1 (Bannister et al., 2001; Lachner et al., 2001) . In this sense, HP1b was suggested to act as a bridge between H3K9me3-enriched chromatin fibers (Hiragami-Hamada et al., 2016) . Interestingly, recent studies have suggested that HP1-mediated compaction also involves phase separation from soluble chromatin (Larson et al., 2017; Strom et al., 2017) . HP1 proteins also act as adapter molecules that link other factors to heterochromatin such as Suv4-20h2 or DNA methyltransferases among others (Fuks et al., 2003; Hahn et al., 2013) .
Despite these advances, the question remains as to the relative contributions of each of HP1 isotype to heterochromatin organization and structure. This inquiry has been hampered by the strong functional redundancy of HP1 proteins, the abundance of all three isoforms in PCH foci, and their ability to homoand hetero-dimerize (Canzio et al., 2014) . Thus, the role of the three isoforms in heterochromatin has been considered to be more or less equivalent. However, the fact that the three isoforms have a distinct pattern of genomic distribution, specific interaction partners, and post-translational modifications, suggests that they likely perform different functions in cell physiology (Kwon and Workman, 2011; Maison and Almouzni, 2004) . This possibility has been supported by recent evidence showing a more direct role of HP1a and HP1g in Suv39h1 function in PCH than in HP1b (Raurell-Vila et al., 2017) . Furthermore, mutational analyses have shown tissue-specific phenotypes in HP1a, HP1b, and HP1g knockout (KO) mice (Aucott et al., 2008; Brown et al., 2010; Maksakova et al., 2011; Singh, 2010) .
The functional differences between HP1a and HP1b are particularly relevant as both isoforms are enriched within PCH and their combined loss abrogates HP1g localization in these regions (Dialynas et al., 2007) . Aiming to understand the specific role of HP1a and HP1b isoforms in PCH, we analyzed the impact of each isoform on heterochromatin structure and organization using mouse embryonic fibroblast (MEF) cells derived from KO mice. Our studies suggest that HP1a plays a key role as an organizer of constitutive heterochromatin regions. Loss of HP1a results in the enrichment of H4K20me3 and H4K27me3 in PCH foci, whereas HP1b mediates a direct functional link with H4K20me3 and Suv420h2. Consistent with non-overlapping roles in PCH organization and structure, each mutant isoform exhibits a different pattern of H4K20me3 and H3K27me3 distribution in PCH that is associated with different types of mitotic aberrations. Our studies also suggest that HP1a and HP1b play opposite roles in CTCF distribution in PCH and other genomic regions. These studies provide insight into the specific roles of HP1 isoforms in heterochromatin structure.
RESULTS
Previous studies have suggested that the localization of endogenous HP1a and HP1b in PCH was broadly co-incident but not complete (Dialynas et al., 2007) . We first aimed to confirm that the pattern of distribution of all three isoforms in PCH foci of NIH 3T3 cells is different. We expressed fluorescence-tagged HP1 isoforms and performed spectral imaging in PCH, which enabled us to correlate the intensity distribution of each isoform (Figure 1A, upper) and their relative localization relative to the foci center or radial position (Figure 1A, lower) . As shown in Figures  1A and S1A-S1C, HP1a and HP1b are enriched in similar regions of PCH, preferentially toward the center of the foci. However, the intensity distribution was not identical, thereby suggesting a distinctive enrichment of both isoforms in PCH structure. HP1g showed a lower degree of correlation with the other two isoforms with a rather more dispersed distribution within the foci (Figure 1A) . Moreover, the loss of either HP1a or HP1b did not alter each other's levels in PCH but did induce an enrichment of HP1g, suggesting that it plays an auxiliary role for both isoforms (Figures S1E and S1F) as has been previously suggested (RaurellVila et al., 2017) . The interplay between the isotypes is also confirmed by the loss of HP1g deposition in PCH upon simultaneous loss of HP1a and HP1b ( Figure S1D ), which has been seen previously (Dialynas et al., 2007) .
HP1a Loss Induces H4K20me3 and H3K27me3 Enrichment in PCH Foci
We first analyzed the histone-modification changes in PCH foci that are associated with the specific loss of each HP1 isoform. To consider the possibility of cell-cycle-dependent events, we performed the analysis at different stages of the cell cycle. A loss of each HP1 isoform was correlated with a small decrease in H3K9me3 and a significant increase (1.5-to 1.7-fold) in H3K4me3 levels in PCH foci at all stages of the cell cycle ( Figures  1B and S2A ), thereby confirming that they are redundant with regard to the deposition of these histone modifications. There was also no significant impact on the DNA methylation levels at major satellite sequences between HP1a and the other isoforms (Figures S2B and S2C) . In stark contrast, a loss of HP1a, but not of HP1b or HP1g, resulted in a significant enrichment of H4K20me3 (around 1.8-fold) and H3K27me3 (around 2-fold) in the PCH foci during all cell-cycle stages ( Figures 1B and S2A) . Notably, increased levels of H4K20me3 were also observed at other genomic regions as well as the PCH (Figures S2A and  S2D ). Chromatin-immunoprecipitation (ChIP) assays confirmed that both H4K20me3 and H3K27me3 were increased in the major satellites of Hp1a À/À MEFs compared to wild-type (WT) cells, while they were decreased in Hp1b À/À and Hp1g À/À cells ( Figure 1C ).
To confirm that the changes in both marks were directly dependent on HP1a, we overexpressed Cre recombinase (R1) in Hp1a À/À MEFs, which excised the promoter-trap Neo cassette that was used to generate the KO and restored HP1a gene integrity and expression (noKO) ( Figure 2A ). As expected, the re-expression of endogenous HP1a by the nuclease-driven removal of the Neo cassette ( Figures 2B, S3A , and S3B) restored the levels of both marks in PCH foci. An identical result was obtained upon the overexpression of ectopic HP1a in Hp1a
MEFs, demonstrating a direct role of HP1a in the control of these marks ( Figures 2C and S3C) . Interestingly, the re-deletion of HP1a (reKO) in noKO cells by FLP recombinase (R2) restored H3K27me3 levels but did not alter H4K20me3 (Figures 2B and S3B) . The reKO generated a short-truncated form of HP1a (Figure S3A ). To rule out any potential effect of the HP1a short-truncated form on H4K20me3, we knocked down HP1a by short hairpin RNA (shRNA) in NIH 3T3 cells. Consistently, HP1a loss resulted in H3K27me3 enrichment in PCH foci (1.6-fold) and no significant increase in H4K20me3 ( Figures 2D, S3D , and S3E) (Hahn et al., 2013) , suggesting a different deposition mechanism in PCH for both marks. We also knocked down HP1b and observed, in all cell-cycle stages except for G 2 /M, a decrease in both H3K27me3 (25% reduction) and H4K20me3 (20% reduction) in PCH foci, supporting a direct role for HP1b in H4K20me3 deposition ( Figures 2D, S3D , and S3E), which prompted us to explore the relationship between HP1b and H4K20me3 in more detail.
HP1b Is Functionally Linked to H4K20me3 and Suv420h2
Previous studies with recombinant HP1 proteins have suggested that all three isoforms may be equivalent in the regulation of H4K20me3 (Hahn et al., 2013) . Interestingly, although we confirmed that all three isotypes interacted equally well with the Suv420h2 in nuclear soluble fractions of the transfected cells (data not shown), we observed a specific interaction between Suv420h2 and HP1b compared to the other isoforms in extracts enriched in digested insoluble chromatin upon highly stringent conditions ( Figure 3A ). Fluorescence resonance energy transfer (FRET) experiments confirmed these observations in vivo with a preferential binding of Suv420h2 to HP1b compared to HP1a and HP1g ( Figures 3B, S4A , and S4C). However, a fluorescence recovery after a photobleaching (FRAP) analysis of the dynamics of Suv420h2 in PCH foci of the WT, Hp1a-, Hp1b-, or Hp1g-deficient MEFs showed a more complex picture. The loss of HP1b resulted in a decreased turnover of Suv420h2 at PCH and did not alter the Suv420h2 mobile fraction, whereas the loss of HP1a resulted in increased turnover of Suv420h2 in PCH compared to WT ( Figures 3C and 3D ). The overexpression of HP1a and HP1b had a small effect on the Suv420h2 residence time ( Figures 3D and S4D ). The decreased turnover upon HP1b loss contrasted with the increase turnover that was observed in HP1a-deficient cells, indicating an antagonistic role of HP1a and HP1b in Suv420h2 dynamics. Notably, HP1g loss on Suv420h2 dynamics induced an effect between HP1a and HP1b, but its overexpression decreased its mobile fraction (Figures 3D and S4D) . These FRAP analyses suggest that each isoform alters Suv420h2 dynamics in PCH in an isoform-specific manner. Taking our results together, we suggest that the effect of HP1b is likely to have a more direct role in Suv420h2 dynamics. A functional link between HP1b/Suv420h2 might also explain the decreased levels of H4K20me3 that were observed in both Hp1b À/À MEFs ( Figure 1C ) and upon shRNAdriven HP1b knockdown ( Figure 2D ). To obtain biochemical support for such an interaction, we undertook hemagglutinin ( Representative images are shown in Figure S2A . ***p < 0.001. (C) ChIP of H3K9me3, H4K20me3, and H3K27me3 in major satellites of indicated MEFs. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
affinity purification of HA-tagged HP1 isoforms, which showed that HP1b-containing chromatin was 1.5-fold enriched in H4K20me3 compared to HP1a or HP1g, whereas H3K9me3 was detected at similar levels with all three isoforms (Figures 3E and S4E) . We next tested the ability of each isoform to bind to H4K20me3 compared to H3K9me3 in peptide pull-downs using nuclear fractions containing HA-tagged HP1 isoforms (see Experimental Procedures). We performed these pull-downs under two different buffer conditions, the classical mild Dignam buffer and the highly stringent radioimmunoprecipitation assay (RIPA) buffer. We observed that all three isoforms bound strongly to H3K9me3-methylated peptide, but only HP1b bound to H4K20me3 resin ( Figure 3F , Dignam). The binding of HP1b to H4K20me3 was more labile than to H3K9me3 because it was abrogated under very stringent RIPA conditions ( Figure 3F , RIPA). These results suggested that, despite a strong redundancy between isoforms, HP1b binds to H4K20me3 with higher affinity than do the other isoforms. Consistently, re-ChIP experiments of endogenous HP1 isoforms (first ChIP) and H3K9me3 or H4K20me3 (second ChIP) of major satellites showed that the ratio H4K20me3/ H3K9me3 in HP1b re-ChIP was clearly higher (1.25) than in HP1a (1) and HP1g (0.3) ( Figure 3G ). This increased co-localization between HP1b and H4K20me3 was not an exclusive feature of PCH since a genome-wide analysis of previously reported ChIP sequencing (ChIP-seq) experiments in mouse embryonic stem cells (ESCs) confirmed a stronger overall correlation between HP1b and H4K20me3 compared to HP1a ( Figure 3H ).
CTCF Cooperates with HP1a in PCH Organization
Both Suv420h2 and H4K20me3 have been linked to cohesin enrichment in PCH (Hahn et al., 2013) . We next tested whether the changes in H4K20me3 in Hp1a À/À MEFs also alter cohesin enrichment in PCH. ChIP experiments showed a 2-fold increase in cohesin levels at PCH in Hp1b À/À MEFs in contrast to Hp1a
and Hp1g À/À ( Figure 4A ). This result suggested that HP1b may have an inhibitory effect on the accumulation of cohesins in PCH and that this enrichment was not associated to H4K20me3 levels. Cohesin distribution has been directly linked to CTCF, which is a major player in global genomic architecture (Cuddapah et al., 2009; Rubio et al., 2008) . This link and the reported link of CTCF to PCH (Mukhopadhyay et al., 2004; Xiao et al., 2015) as well as HP1a (Agirre et al., 2015) , led us to hypothesize that the H4K20me3-independent cohesin enrichment in Hp1b À/À MEFs may be related to abnormal levels of CTCF in PCH. Accordingly, we observed that, although the levels of CTCF in major satellites seem to be under the detection limit of ChIP in WT, Hp1a
, and Hp1g À/À cells, we did detect a significant enrichment (>7-fold) of CTCF in Hp1b À/À MEFs ( Figure 4B ).
In contrast, no CTCF enrichment was detected in minor satellites ( Figure 4B ). Although CTCF was not detected in PCH by ChIP analysis, a detailed co-localization analysis of the endogenous CTCF signal within PCH confirmed the presence of CTCF in these regions ( Figure S5B ). These data are consistent with previous reports (Mukhopadhyay et al., 2004; Xiao et al., 2015) and indicate that CTCF is present in these regions either in limiting levels or under very specific conditions. Prompted by these data, we tested whether CTCF interacts with any of the HP1 isoforms in vitro and in vivo. We found that CTCF bound specifically to ). *p < 0.05, **p < 0.01, ***p < 0.001. (E) H3K9me3/H3 and H4K20me3/H4 levels in affinity purification of HA-tagged HP1 isoforms. Upper: schematic diagram of the experiment. Chromatin fractions of HEK293F cells expressing HA-tagged HP1 isoforms were digested with Benzonase and affinity purified with HA resin. Levels of H3K9me3 and H4K20me3 were normalized with histones H3 and H4, respectively, and the ratios in HP1b and g pull-downs were quantified (n = 3) and represented relative to HP1a. A representative experiment is shown in Figure S4E . *p < 0.05, ***p < 0.001. (F) Pull-down of HA-tagged HP1 isoforms with H3 or H4 (unmodified or H4K20me3)-biotinylated-streptavidin-agarose performed with HEK293F cell extracts generated in mild (Dignam) or stringent (RIPA) conditions. (G) Re-ChIP experiments (n = 3) of endogenous HP1 isoforms (ChIP #1) and H3K9me3 or H4K20me3 (ChIP #2) in major satellites of NIH 3T3 cells. The ratio H4K20me3/H3K9me3 is shown for each isoform. **p < 0.01, ***p < 0.001. (H) Correlation of the genome-wide co-localization between H4K20me3 and HP1a or HP1b in mouse ESCs. Boxplot of the log reads of H4K20me3 in the regions occupied by HP1a and HP1b based on previously published ChIP-seq experiments. ****p < 0.0001. and S5A). Further supporting the antagonism between HP1a and HP1b in PCH, CTCF EGFP was significantly scarcer in the PCH foci of HP1a-deficient MEFs, suggesting that HP1a is directly related to CTCF localization to PCH ( Figure 4F ). By contrast, a loss of HP1b induced, in around 45% of cells analyzed, a dramatic enrichment of CTCF in PCH regions ( Figure 4F ), which was correlated with a global increase in CTCF protein levels without altering CTCF gene expression ( Figure S5D ; data not shown). These data suggest that HP1b loss results in enhanced spreading of CTCF beyond its normal sites of localization. Confirming this hypothesis, CTCF was detected outside the H19 or HP1a localization ( Figures 4G and S5C) . Altogether, these evidences suggest that CTCF collaborates with HP1a defining specific chromatin domains within PCH.
Depletion of HP1a, but Not of HP1b or HP1g, Induces Decreased Accessibility and In Vivo Hypercompaction of PCH A key question concerns the role of HP1 proteins in chromatin compaction. Such a role is implied by the observation that H4K20me3 has been directly linked to compaction levels in PCH foci through cohesins and that HP1 proteins recruit Suv420h2, which is the enzyme that is responsible for the trimethylation of H4K20 (Hahn et al., 2013) . Accordingly, we investigated whether the changes that were observed in the HP1a-and HP1b-deficient cells were associated to changes in the levels of compaction of the PCH foci in vitro and in vivo.
In vitro, we performed a classic micrococcal nuclease (MNase) digestion of the genome followed by a Southern blot with an [ 32 P]-labeled probe of the satellite. The loss of HP1a induced a decrease in accessibility of the PCH foci. By contrast, the loss of HP1b and, to a lesser extent, of HP1g, induced enhanced digestion of PCH chromatin DNA by MNase ( Figures 5A  and 5B ). This effect was not restricted to PCH foci but also affected the accessibility of chromatin globally. The loss of HP1a also resulted in around a 20% increase in linker-DNA length compared to WT cells ( Figure 5C ). Longer linker DNA has been associated with higher chromatin compaction (Szerlong and Hansen, 2011) . Next, we investigated the effects of HP1 loss on chromatin compaction within PCH foci in vivo using FLIM-FRET assays. This method allowed us to measure the degree of compaction of both PCH foci and the whole genome in live cells by expressing H2B fused to two different fluorophores (GFP and RFP) (Llè res et al., 2009 ). Higher chromatin compaction was correlated with higher FRET efficiency between H2B-GFP and H2B-RFP, which resulted in a lower half-life of the FRET donor GFP (FLIM) ( Figure 5D ). A FLIM-FRET analysis of live cells confirmed results that were obtained in vitro because HP1a deficiency produced a decrease in the GFP half-life (pamp) as a consequence of a 1.8-fold increase in FRET efficiency. In contrast, HP1b-and HP1g-deficient cells showed no significant changes in their GFP half-life ( Figures 5E, 5F , S5E, and S5F). These results indicate that HP1a is a key player in the global organization of PCH by regulating its state of compaction.
Our in vitro and in vivo studies indicate that, in addition to a common redundant role of all three isoforms, HP1a and HP1b have unique isoform-specific roles in genome stability. To test this hypothesis, we studied the frequency of mitotic abnormalities in WT, Hp1a aberrations were strikingly different to those found in Hp1b
MEFs. The loss of HP1a resulted in an increased number of merotelic and syntelic attachment defects ( Figure 5G ), whereas the loss of HP1b resulted in high frequency of multipolar spindle formation. Interestingly, the loss of HP1g resulted in less frequent defects that were a mixture of those found in Hp1a À/À and Hp1b À/À MEFs, indicating that HP1g shares some redundancy with the other isoforms ( Figures 5G and 5H ).
DISCUSSION
Our work suggests that each HP1 isoform makes a distinctive contribution to the organization and structure of PCH foci. The individual roles are most clearly manifest in chromosomal abnormalities found in isoform-specific mutant MEFs. The increased frequency of merotelic attachments found in Hp1a
, which resulted from the simultaneous binding of a single kinetochrore to both spindle poles (Figures 5G and 5H) , have been previously associated to a deficient Clr4/Swi6 function in Schizosaccharomyces pombe (Gregan et al., 2007) . By contrast, Hp1b
MEFs showed defects in mitotic spindle multipolarity ( Figures  5G and 5H ), which may be related to the de-condensed phenotype observed in these chromosomes. Our work indicates that HP1a plays a direct role in restraining H4K20me3 and H3K27me3 in PCH. Accordingly, we suggest that HP1a acts as an organizer of PCH in conjunction with CTCF. This is in agreement with the described localization of CTCF in centromeric/ PCH regions (Mukhopadhyay et al., 2004; Rubio et al., 2008) . Our data also suggest that HP1a may recruit CTCF to specific sites within PCH because the loss of HP1a causes a significant delocalization of CTCF-EGFP. Notably, we did not detect CTCF by ChIP in WT, Hp1a À/À , and Hp1g À/À cells ( Figure 4B) although the co-localization experiments of endogenous CTCF ( Figure S5B ) and GFP-CTCF distribution and FRET analysis (Figures 4E and 4F) confirmed the presence of CTCF in PCH as shown previously (Mukhopadhyay et al., 2004; Xiao et al., 2015) . Our data suggest that HP1b act in opposition to HP1a with regard to H4K20me3 and H3K27me3 within PCH foci. Moreover, in Hp1b À/À cells, we observed a global enrichment of CTCF in large regions of the genome including PCH (Figure 4F ), thereby suggesting a role for HP1b in restraining the localization of CTCF to specific loci and, thereby, likely controlling chromatin boundaries. This role is supported by our observation that loss of HP1b results in enrichment of CTCF outside its normal confines. Specifically, we observed that, in Hp1b
cells, CTCF is found in the 6-kb-long LINE-L1 elements at the promoter and also 2 kb away, at the ORF2 ( Figure 4C ). A similar observation was observed at the H19 ICR in Hp1b À/À cells (Figure 4C) . The latter result is in keeping with the suggestion that HP1b may regulate genomic imprinting (Singh, 2016) . Because there does not appear to be any CTCF canonical motifs downstream of the H19 ICR or in LINE-L1s, the observed spreading is unlikely to be related to a direct binding of CTCF to DNA but more likely dependent on other factors. Our work suggests that the relationship between H3K27me3 and H4K20me3 with HP1a is different. The increased levels of H3K27me3, but not of H4K20me3, that were observed upon downregulation of HP1a suggest that the specific regulation of H4K20me3 may be restricted to an earlier developmental stage prior to the specification of the fibroblast lineage. In support of this idea, the establishment of both HP1a and H4K20me3 seems to take place at the same time during late development (Wongtawan et al., 2011) . Recent work has suggested that HP1a has a more significant role in the establishment of H3K9me3 mark than in its maintenance (Hathaway et al., 2012) . This function may also be true for H4K20me3 since the re-expression of HP1a in Hp1a À/À could re-establish the H4K20me3 levels in PCH, but its re-deletion did not have any clear effect ( Figures  2A-2C ).
We have also revealed an unexpected link between HP1b and H4K20me3. In vivo HP1b preferentially interacts with Suv420h2 within the PCH foci and regulates its dynamics. Consistently, HP1b recognizes H4K20me3-methylated peptides and HP1b-containing chromatin is enriched in H4K20me3 and tends to localize with H4K20me3 in major satellites compared to other isoforms. Moreover, a ChIP-seq analysis shows a higher genome-wide correlation in ESCs between HP1b and H4K20me3 compared to HP1a.
One of the most striking observations that we found was the hypercompaction of the PCH structure in HP1a-deficient cells. Hypercompaction in HP1a-deficient cells was associated with an increased enrichment in H4K20me3 and H3K27me3 and a longer linker DNA ( Figure 5C ). This result was surprising because a previous study reported that artificial binding of LacR-tagged HP1a or HP1b to Lac operon-regulated transgenes resulted in chromatin compaction (Verschure et al., 2005) . These apparently conflicting observations may be reconciled if one population of HP1a molecules is involved in PCH compartmentalization while another plays, along with the other isoforms, a more redundant role.
Based on our data, we propose that, despite a well-established functional redundancy between isoforms in PCH, HP1a and HP1b play different roles in the organization and structure of PCH. Our studies also suggest a model of heterochromatin organization whereby HP1a maintains, together with CTCF, the internal structure and compaction of PCH foci by restricting the distribution of H4K20me3 and H3K27me3. These findings offer insight into the structural organization of the genome and provide a perspective on the role of HP1 isoforms and their functional link with heterochromatin structure, genome organization, and stability.
EXPERIMENTAL PROCEDURES
FRET, FLIM-FRET, and FRAP Assays Leica SP5 confocal and Acceptor photo-bleaching methods were used to measure the FRET in PCH foci. %FRET was calculated taking 100% as the FRET value that was obtained for GFP-RPF (positive control) and 0% as the value obtained for the FRET value that was obtained for the donor construct alone. RFP protein from PCH foci was bleached by using a maximum laser 561 power obtaining $80% of acceptor-intensity bleaching. The FLIM-FRET experiments were performed as indicated (see Supplemental Experimental Procedures). All experiments were performed at least in 10 independent assays and on 50 different cells. FRAP experiments were carried out as previously described (see Supplemental Experimental Procedures).
Generation of noKO and reKO Cells
The generation of Hp1a
, and Hp1g À/À mouse and associated
MEFs was previously described (Aucott et al., 2008; Brown et al., 2010; Maksakova et al., 2011) . The process of conversion from KO to reKO was similar as it was shown for Hp1g À/À (Brown et al., 2010) . Hp1a À/À (Cbx5 ChIPs and re-ChIPs ChIPs were performed with 3-5 3 10 6 cells as previously described (Rodrí-guez-Ubreva and Ballestar, 2014). In re-ChIP experiments, the first ChIP (HP1) was eluted with 10 mM Tris-EDTA (TE) and 20 mM DTT and diluted 20 times in dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl 8.1, 167 mM NaCl, and protease inhibitors) and proceeded to the second ChIP (H3K20me3 or H3K9me3).
Peptide Pull-Down of HP1 Isoforms Biotinylated peptides spanning histone H4 residues 1-23 or 1-21 of H3 (unmodified or H3K9me3) were obtained from Anaspec (Fremont, CA). 100 mg of peptides were pre-bound to streptavidin agarose (Millipore) and then incubated at 4 C overnight (O/N) with nuclear extracts from 293F cells expressing the HA-tagged HP1 isoforms either prepared according to the Dignam or RIPA method (see Supplemental Experimental Procedures).
Statistical Analysis
The statistical analysis was performed using a multivariant ANOVA ( 
